HIGHLIGHTS
- who: Changchuan Jiang from the (UNIVERSITY) have published the article: Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis, in the Journal: (JOURNAL) of December/31,/2017
- what: This study examines and compares the clinical outcome of de novo metastatic HER2-low (IHC1+ or IHC2+/ISH-Negative) and HER2-zero (IHC 0) breast cancer using the NCDB, a national cancer outcome dataset in the United_States.
- how: The results showed that HER2-low breast cancers had lower tumor grades and fewer visceral metastases. The results were partially consistent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.